Topics

PARP Inhibitors Center Stage for Ovarian Cancer

06:50 EDT 7 Oct 2019 | Medscape

Dr Susana Banerjee reviews three trials using PARP inhibitors that are likely to change first-line therapy for ovarian cancer.
Medscape Oncology

Original Article: PARP Inhibitors Center Stage for Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "PARP Inhibitors Center Stage for Ovarian Cancer"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...